Dr. Harald-Gerhard Geppert

Angestellt, Director Regulatory Affairs, Head of Regulatory Operations, CMRA, QIAGEN GmbH

Hilden, Deutschland

Fähigkeiten und Kenntnisse

Regulatory affairs
in vitro diagnostic
medical device
class (I
II
III)
pre-IDE
510(k)
QSR
quality management
clinical and analytical validation
drug development
therapeutics
monitoring
individualized/personalized medicine
polyclonal and monoclonal antibodies
Regulierung
Medical Devices
ISO 13485

Werdegang

Berufserfahrung von Harald-Gerhard Geppert

  • Bis heute 1 Jahr, seit Juni 2023

    Director Regulatory Affairs, Head of Regulatory Operations, CMRA

    QIAGEN GmbH
  • Bis heute 3 Jahre und 2 Monate, seit Apr. 2021

    Associate Director, Medical Safety Lead, CMRA

    QIAGEN GmbH
  • 3 Jahre, Apr. 2018 - März 2021

    Associate Director Regulatory Affairs

    QIAGEN GmbH

    REGULATORY AFFAIRS (IVDR 2017/746, 98/79/EC, etc.) in the context of in vitro diagnostic medical devices

  • 5 Jahre und 9 Monate, Juli 2012 - März 2018

    Senior Manager Regulatory Affairs

    QIAGEN GmbH

    REGULATORY AFFAIRS (focus: 93/42/EEC, 98/79/EC, MPG, DIN EN ISO 13485, DIN EN ISO 14971, 21CFR820, FDA regulations) in the context of in vitro diagnostic medical devices

  • 2 Jahre und 11 Monate, Aug. 2009 - Juni 2012

    Manager Regulatory Affairs

    QIAGEN GmbH

    REGULATORY AFFAIRS (focus: 93/42/EEC, 98/79/EC, MPG, DIN EN ISO 13485, DIN EN ISO 14971, 21CFR820, FDA regulations) in the context of in vitro diagnostic medical devices

  • 2 Jahre, Aug. 2007 - Juli 2009

    Head of Regulatory Affairs

    mosaiques diagnostics GmbH

    REGULATORY AFFAIRS (focus: 93/42/EEC, 98/79/EC, MPG, FDA regulations) and quality management representative (focus: DIN EN ISO 13485, DIN EN ISO 14971, 21CFR820) in the context of in vitro diagnostic medical devices, safety officer (MPG)

  • 2 Jahre und 7 Monate, Jan. 2007 - Juli 2009

    Manager Therapeutic & Clinical Applications

    mosaiques diagnostics GmbH

    BUSINESS DEVELOPMENT (focus: establishment of business connections, writing of press releases, news letters, publications, presentations, supervision of internet presence), contract negotiations and direction of studies in cooperation with the pharmaceutical industry

  • 4 Jahre und 4 Monate, Sep. 2002 - Dez. 2006

    Project manager (Antibody generation and Target validation)

    GANYMED Pharmaceuticals AG

    DEVELOPMENT and CHARACTERISATION of POLYCLONAL and MONOCLONAL ANTIBODIES, immunization of mice and rabbits, hybridoma techniques, recombinant protein production (bacterial, in vitro translation, mammalian cells), chromatography, assay development (focus: immunofluorescence microscopy, ELISA, WB), cell and tissue culture, project management, reporting, safety officer

Ausbildung von Harald-Gerhard Geppert

  • Cellular Biochemistry and Biophysics Program

    Cornell University - Memorial Sloan Kettering Cancer Center

    Expression systems, animal models, cell and tissue culture

  • Clinical research unit

    Munich Technical University - University hospital rechts der Isar

    Expression systems, cell and tissue culture, confocal immunofluorescence microscopy

  • Department of Chemistry/Biochemistry

    University of Bielefeld

    Cloning, gene expression, recombinant protein expression systems (E. coli, P. pastoris, Mammalian cells), chromatography, development of polyclonal antibodies, assay development, cell and tissue culture

Sprachen

  • Deutsch

    -

  • Englisch

    -

Interessen

Professional advancement/development
golf
diving
skiing
athletic and endurance sports
photography

21 Mio. XING Mitglieder, von A bis Z